6.90% p.a. Multi Barrier Reverse Convertible
Bayer, Novartis, Novo Nordisk, Roche
Valor
128207113
SIX Symbol
NIZRCH
ISIN
CH1282071138
Issue Terms
Expired
Identifiers
128207113
CH1282071138
NIZRCH
Yield Enhancement
Barrier Reverse Convertible
Callable Multi Barrier Reverse Convertible
1230
Parameters
Raiffeisen Switzerland Cooperative, St. Gallen, Switzerland
Quarterly
6.90% p.a.
Cash Settlement or Delivery of Underlying
Dirty (accrued interest included)
100%
CHF 1'000.00
CHF
Listed
Yes
Life Cycle
1.5 Years
17 Nov 2023
24 Nov 2023
24 Nov 2023
04 Dec 2023
04 Dec 2023
28 May 2025
04 Jun 2025
Barrier
50.00%
Continuous barrier observation (american)
24 Nov 2023 - 28 May 2025
No
21.01%
Product Specific Features
100.00%
Performance
Name Market Price Initial Fixing Level Barrier Level Distance to Barrier Strike Level Distance to Strike
Name Market Price
EUR 24.73
Initial Fixing Level EUR 32.65 Barrier Level EUR 16.32 Distance to Barrier 33.98% Strike Level EUR 32.65 Distance to Strike -32.03%
Name Market Price
CHF 92.73
Initial Fixing Level CHF 86.79 Barrier Level CHF 43.40 Distance to Barrier 53.20% Strike Level CHF 86.79 Distance to Strike 6.41%
Name Market Price
DKK 453.65
Initial Fixing Level DKK 716.70 Barrier Level DKK 358.35 Distance to Barrier 21.01% Strike Level DKK 716.70 Distance to Strike -57.99%
Name Market Price
CHF 260.20
Initial Fixing Level CHF 238.70 Barrier Level CHF 119.35 Distance to Barrier 54.13% Strike Level CHF 238.70 Distance to Strike 8.26%
Coupons
Payment Date Amount
Payment Date06 Mar 2024 Amount1.725%
Payment Date04 Jun 2024 Amount1.725%
Payment Date04 Sep 2024 Amount1.725%
Payment Date05 Dec 2024 Amount1.725%
Payment Date07 Mar 2025 Amount1.725%
Payment Date04 Jun 2025 Amount1.725%
Early Redemption
Observation Date Redemption Amount
Observation Date28 Nov 2024 Redemption Amount100.00%
Observation Date28 Feb 2025 Redemption Amount100.00%